Uncategorized

AbbVie has been dealt a major setback in its efforts to bring a novel treatment for motor fluctuations in adults with advanced Parkinson’s disease to … Read more

Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical company dedicated to bringing therapies to those suffering from serious, rare and life-threatening diseases, has entered into a … Read more

Tenax Therapeutics, Inc. (Nasdaq: TENX), a specialty pharmaceutical company dedicated to developing and commercializing products that address critical cardiovascular and pulmonary diseases with high unmet … Read more

Today, Oculis Holding AG (Nasdaq: OCS) rings the Nasdaq opening bell in celebration of its public listing on the Nasdaq Stock Market! Oculis is a … Read more

Aziyo Biologics, Inc. (Nasdaq: AZYO) and Sientra, Inc. (Nasdaq: SIEN) have joined forces to expand the distribution of Aziyo’s innovative SimpliDerm product line. This agreement … Read more

Standard BioTools Inc. (Nasdaq:LAB) is delighted to announce that its Compensation Committee, comprised entirely of independent directors, has granted a generous equity award to an … Read more

Shares of Altimmune tumbled 55% Tuesday after the company released mid-stage data on its obesity drug, pemvidutide, which showed a 10% reduction in patients’ weight. … Read more

Tuesday marked a major milestone for Gilead’s Kite Pharma, as their Yescarta treatment became the first in nearly three decades to show an improvement in … Read more

Flare Therapeutics announced a massive success on Wednesday, with its Series B funding round raising a whopping $123 million. This impressive figure will be used … Read more

On Wednesday, 89bio announced that the data from the Phase IIb ENLIVEN trial revealed that their pegozafermin had achieved its primary histology endpoint and reduced … Read more

BioBam, a leading bioinformatics software provider, is proud to announce the renewal of its exclusive worldwide KEGG license from Pathway Solutions Inc. With this renewed … Read more

Invitae (NYSE: NVTA), a leading medical genetics company, is joining forces with Deerfield Management Company, an experienced healthcare investment firm, to revolutionize drug discovery and … Read more

Medexus Pharmaceuticals (TSX: MDP; OTCQX: MEDXF) is thrilled to announce that it has acquired the exclusive Canadian rights to terbinafine hydrochloride nail lacquer, provided by … Read more

Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company dedicated to improving lives through innovative medicines, is pleased to announce that the U.S. Food and Drug … Read more

WILLOW BIOSCIENCES (TSX: WLLW) (OTCQB: CANSF) and SUANFARMA are proud to announce that, together with SUANFARMA’s CIPAN manufacturing site, they have successfully completed the development … Read more

Remix Therapeutics, a biotechnology company dedicated to discovering small molecule treatments to target the root causes of illness, is proud to welcome Robert Gagnon as … Read more

Kineta, Inc. (Nasdaq: KA) is delighted to announce that the company will be presenting its ground-breaking VISTA clinical program at the American Association for Cancer … Read more

Mesoblast Limited (ASX:MSB; Nasdaq:MESO), the global leader in allogeneic cellular medicines for inflammatory diseases, recently announced that the United States Food and Drug Administration (FDA) … Read more

Flare Therapeutics Inc., a biotechnology company dedicated to discovering precision medicines for cancer and other diseases, has closed a massive $123 million Series B financing … Read more

Sage Therapeutics, Inc. (Nasdaq: SAGE), a pioneering biopharmaceutical company dedicated to improving brain health, is proud to announce its participation in the Stifel 2023 CNS … Read more

Matrisys Bioscience, a private, clinical-stage pharmaceutical company focused on developing live biotherapeutic products (LBPs) for chronic dermatologic indications, is proud to announce that its scientific … Read more

IGC Pharma, Inc. (formerly Globalization Capital, Inc.) is launching a rebranding initiative to better represent its strategic focus and vision for the future. On March … Read more

The COVID-19 pandemic has proved to be a massive boon for many biotech companies, resulting in large profits and handsome pay increases for their chief … Read more

Takeda is on the brink of a major breakthrough with its experimental drug for plaque psoriasis, TAK-279. Following a successful Phase IIb study that met … Read more

Karuna Therapeutics has achieved a major milestone in its mission to bring a revolutionary new treatment for schizophrenia to the public: the results of its … Read more

Friday was a devastating day for Sangamo Therapeutics, as two of their most powerful partners, Novartis and Biogen, announced that they were ending their collaborations … Read more

The Centers for Medicare & Medicaid Services (CMS) has awarded Dynanet a Prime contract as part of the $1,000,000,000 Agile Collaboration and Modernization Endeavors (ACME) … Read more

Prestige Biopharma has been granted Fast Track designation from the U.S. Food and Drug Administration (FDA) for PBP1510 (International Non-proprietary name: Ulenistamab), a revolutionary potential … Read more

CTI BioPharma Corp. (Nasdaq: CTIC), a commercial biopharmaceutical company dedicated to the development and commercialization of groundbreaking treatments for blood-related cancers, proudly announced the granting … Read more

It was a story that could have come out of a fairytale book. A small American vaccine maker rose to the challenge of the pandemic … Read more

NS Pharma is delighted to take part in the 2023 Muscular Dystrophy Association’s Clinical & Scientific Congress in Dallas, Texas! We are proud to be … Read more

Castle Biosciences, Inc. (Nasdaq: CSTL) has recently shared new performance data from a multi-center, independent cohort that confirms the independent risk-stratification of DecisionDx®-SCC (the Company’s … Read more

Connect Biopharma Holdings Limited (Nasdaq: CNTB) has announced the promising results of Stage 1 of its pivotal CBP-201 China trial in moderate-to-severe atopic dermatitis (AD). … Read more

Civica Inc. is proud to announce that it will be producing insulins for the State of California’s CalRx Biosimilar Insulin Initiative. Once approved, Civica’s biosimilar … Read more

Candesant Biomedical, a medical device company devoted to providing non-invasive treatments for hyperhidrosis, has unveiled the results of its groundbreaking clinical trial for its revolutionary … Read more

Acelyrin, Inc, a late-stage clinical biopharma company dedicated to delivering transformative medicines in immunology, has announced remarkable data from their Phase 2b/3 trial in patients … Read more

Amgen announced a major restructuring plan on Friday with the aim of weathering the impacts of falling drug prices and rising inflation. As part of … Read more

Daiichi Sankyo was unimpressed with the results of the Phase III CLEAR trial of Esperion Therapeutic’s cholesterol-lowering candidate Nexletol (bempedoic acid), as the results were … Read more

It’s been an eventful start to the year for life science companies, with numerous firms expanding their pipelines and joining forces with resource-limited organizations to … Read more

Pfizer and Astellas are celebrating the positive topline Phase III results for Xtandi (enzalutamide) announced on Thursday, raising hopes of adding another indication to the … Read more

Vanda Pharmaceuticals, Inc. (VNDA: Nasdaq) is pleased to announce the appointment of Tage Honoré, Ph.D., D.Sc. to its Board of Directors, effective March 15, 2023. … Read more

Tiziana Life Sciences Plc (Nasdaq: TLSA), a pioneering biotechnology company developing cutting-edge immunomodulation therapies, has recently been highlighted in a FORBES article. The article focuses … Read more

Predictive Oncology Inc. (NASDAQ: POAI) and Cancer Research Horizon, the innovation engine of Cancer Research UK (CRUK), have joined forces to develop next-generation oncology drugs … Read more

SB17, the proposed biosimilar to Stelara1 (ustekinumab), has proved its mettle in a Phase 1 clinical study with healthy volunteers. It demonstrated pharmacokinetic (PK) bioequivalence … Read more

CANbridge Pharmaceuticals, Inc. (1228.HK) is delighted to announce that long-term follow up data from the Phase 1/2 study of CAN008 (asunercept) plus temozolomide/radiotherapy (TMZ/RT) in … Read more

Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (formerly KemPharm, Inc.), a rare disease therapeutics company, has joined forces with the Sleep Data Initiative, led by RARE-X and … Read more

Kelyniam Global (OTC: KLYG), a leader in the innovative field of custom cranial implants, is proud to report outstanding results for its year ended December … Read more

Tiziana Life Sciences Plc. (Nasdaq: TLSA), a biotechnology company developing innovative immunomodulation therapies through cutting-edge drug delivery methods, has today announced that its Chairman and … Read more

AMP, a leader in the medical aesthetic services industry, is proud to announce its strategic partnership with Destination Aesthetics™ (DA), the top Medical Spa in … Read more

The U.S. Food and Drug Administration (FDA) has decided to move forward with a meeting of its advisory committee regarding Sarepta’s investigational gene therapy for … Read more

NeoGenomics, Inc. (NASDAQ:NEO) is thrilled to announce the commercial launch of its highly anticipated liquid biopsy test, RaDaR®, for molecular/minimal residual disease (MRD). RaDaR is … Read more

Today, Saol Therapeutics, a privately held, clinical-stage pharmaceutical company, announced an exciting new agreement with Medosome Biotec, LLC that will allow them to use their … Read more

Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) is proud to announce that the first participant has been successfully dosed in their Phase 2 clinical trial of … Read more

Purple Biotech, a clinical-stage company developing groundbreaking therapies that exploit the power of the tumor microenvironment, today released exciting results from their Phase 1 dose … Read more

TELA Bio, Inc. (NASDAQ: TELA) is proud to share the results of six groundbreaking studies published in 2022, which demonstrate the efficacy of their revolutionary … Read more

Invitae (NYSE: NVTA), a leading medical genetics company, is proud to welcome W. Michael Korn, M.D., as its new chief medical officer for oncology. Dr. … Read more

Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical-stage research and development company focused on developing cancer treatments of the future, has announced the successful dosing of … Read more

Arbutus Biopharma Corporation (Nasdaq: ABUS) has taken a major step forward in its mission to provide a potential functional cure for hepatitis B virus (HBV) … Read more

MediWound Ltd. (Nasdaq: MDWD), a leading biopharmaceutical company that specializes in developing advanced biotherapeutic solutions for tissue repair and regeneration, is pleased to announce the … Read more

Tonix Pharmaceuticals, Inc. (Nasdaq: TNXP) has announced the enrollment of the first participant in the Phase 2 ‘UPLIFT’ clinical trial for TNX-601 ER1 (tianeptine hemioxalate … Read more

Cognition Therapeutics Inc. (NASDAQ: CGTX) has received a green light from the U.S. Food and Drug Administration (FDA) to move forward with their Investigational New … Read more

Scholar Rock (NASDAQ: SRRK) announced that they have granted a newly hired employee incentive equity awards covering an aggregate of 26,250 shares of their common … Read more

ReCode Therapeutics, a private, clinical-stage genetic medicines company, is leading the way with the next wave of mRNA and gene correction therapeutics. Today, the first … Read more

Resolve Biosciences, a leader in Molecular Cartography™ technology, has announced the appointment of John Stark as its new Chief Executive Officer. With this change, Jason … Read more

Edesa Biotech, Inc. (NASDAQ:EDSA), a clinical-stage biopharmaceutical company that focuses on inflammatory and immune-related diseases, has announced that after successful negotiations with the U.S. Food … Read more

ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) and its independently-operating subsidiary Talem Therapeutics LLC have teamed up with Libera Bio S.L. to tackle the challenge of “undruggable” … Read more

Perspectum Diagnostics, a pioneer in precision health, is revolutionizing medical imaging with its innovative tools to diagnose metabolic diseases and cancer. The company has just … Read more

Nanite Inc. is thrilled to announce an exciting investment from the Cystic Fibrosis Foundation – a whopping $2 million! This funding will be used to … Read more

As the world begins to move past the devastating effects of the pandemic, drug affordability has become a major issue for many patients in the … Read more

Veru has announced its intention to press forward with the late-stage development of sabizabulin, despite the FDA’s rejection of its Emergency Use Authorization (EUA) application … Read more

RAPT Therapeutics, Inc., a clinical-stage biopharmaceutical company that is dedicated to developing innovative oral small molecule therapies to address unmet needs in inflammatory diseases and … Read more

XORTX Therapeutics Inc., a late-stage clinical pharmaceutical company focused on developing innovative therapies to treat progressive kidney disease, is pleased to announce that it has … Read more

Puma Biotechnology, Inc. (NASDAQ: PBYI) has just released the results of an exciting clinical trial investigating the potential of alisertib to treat endocrine-resistant advanced breast … Read more

Oragenics Inc. (NYSE American: OGEN) is thrilled to announce the successful results of its lantibiotics platform in combating multiple resistant pathogens. This novel class of … Read more

Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) has appointed Eric Crombez, M.D., as its new chief medical officer and executive vice president, effective May 1, 2023. Dr. … Read more

TScan Therapeutics, Inc. (Nasdaq: TCRX) is thrilled to announce that the first patient has been successfully dosed as part of its Phase 1 umbrella trial … Read more

Keytruda (pembrolizumab) is a revolutionary drug that has revolutionized cancer therapy, earning a staggering $21 billion in 2022 alone. Its presence has been felt across … Read more

On Friday, without warning, Silicon Valley Bank (SVB) shocked the financial world with its sudden and unexpected failure. On Monday, President Biden declared that he … Read more

Novartis is taking decisive steps to focus on its growth areas, as evidenced by its decision to sell off some of its ophthalmology portfolio assets, … Read more

Cambrian BioPharma is making a big move in the longevity biotech space with the launch of Amplifier Therapeutics. This clinical-stage company is focused on developing … Read more

Therapeutic Solutions International (TSOI) has made a groundbreaking discovery that has the potential to revolutionize treatments for Chronic Obstructive Pulmonary Disease (COPD). By studying a … Read more

Ratio Therapeutics Inc., a pioneering pharmaceutical company dedicated to developing targeted radiotherapeutics for cancer treatment, is delighted to welcome Dr. Noel Monks as its new … Read more

Combined Therapeutics Inc. (CTx) has reinforced its intellectual property position in mRNA vaccine technology through the issuance of U.S. Patent 11,596,685 by the United States … Read more

Evergreen Theragnostics, a clinical stage contract development and manufacturing organization (CDMO) developing innovative radiopharmaceuticals for cancer therapy, has successfully completed a $15M Series B capital … Read more

Revelation Biosciences Inc. (NASDAQ: REVB) is thrilled to announce the addition of two esteemed scientists, Julia Bohannon, Ph.D. and Antonio Hernandez, M.D., to its scientific … Read more

Sanofi, one of the world’s largest pharmaceutical companies, announced Monday that it has struck a deal to acquire diabetes leader Provention Bio for an impressive … Read more

Hours after Sanofi and Provention Bio made headlines with a potential biopharma deal, Pfizer one-upped them with a surprise announcement – it had won the … Read more

This week, the FDA has an exciting agenda lined up, with a target action date and an advisory committee meeting that could be a game-changer … Read more

Genome editing has been a much-debated topic in recent years, with the emergence of CRISPR technology in the spotlight. Scientists and investors alike have been … Read more

In a stunning move, the California Department of Financial Protection and Innovation (DFPI) recently shut down the prestigious Silicon Valley Bank (SVB), one of the … Read more

Sight Sciences, Inc. (Nasdaq: SGHT) is thrilled to announce the US launch of the Ergo-Series of the OMNI® Surgical System, the latest in eyecare technology. … Read more

Are you ready to experience the power of AI? ChatGPT is a chatbot that uses advanced artificial intelligence to respond to questions and prompts in … Read more

AstraZeneca’s groundbreaking drug Tagrisso (osimertinib) has demonstrated a remarkable boost to overall survival (OS) as an adjuvant treatment for early non-small cell lung cancer (NSCLC) … Read more

Bayer is making a major commitment to the United States, dedicating an impressive $1 billion investment to pharmaceutical R&D in 2023. This infusion of capital … Read more

Eli Lilly has had a tough time in its search for an Alzheimer’s disease treatment this year, as the latest data released from the Phase … Read more

Clene Inc.’s gold nanocrystal therapy for ALS, although missing the initial mark, still offers hope. On Thursday, the company released encouraging results from an exploratory … Read more

QurAlis, a biotech company pioneering a biomarker-driven approach to treating ALS, announced a successful conclusion to its oversubscribed Series B round on Thursday, raising a … Read more

InnoCare Pharma (HKEX: 09969; SSE: 688428), a pioneering biopharmaceutical company dedicated to the treatment of cancer and autoimmune diseases, is proud to announce that the … Read more

Allorion Therapeutics, a biotech powerhouse in precision medicine for oncology and autoimmune diseases, has just closed a remarkable $50 million Series B financing round, co-led … Read more

AusperBio, the joint venture of Ausper Biopharma Co. Ltd. and AusperBio Therapeutic, Inc., is proud to announce the successful completion of the first cohort dosing … Read more

Scilex Holding Company, a majority-owned subsidiary of Sorrento Therapeutics, Inc., is excited to announce a revolutionary territory distribution agreement for their acclaimed non-opioid pain management … Read more

Yield10 Bioscience, Inc. (Nasdaq:YTEN) is set to provide a comprehensive update on the company’s fourth quarter and full year 2022 financial results on Tuesday, March … Read more

QSAM Biosciences Inc. (OTCQB: QSAM) is thrilled to announce that the U.S. Food & Drug Administration has cleared the Company’s amended clinical trial protocol, significantly … Read more

Editas Medicine, Inc. (Nasdaq: EDIT) has announced the appointment of Linea Aspesi as its Executive Vice President and Chief People Officer. Ms. Aspesi will leverage … Read more

Oragenics, Inc. (NYSE American: OGEN), a biotechnology company committed to combating infectious diseases such as COVID-19, is thrilled to welcome Janet Huffman as Chief Financial … Read more

After three years of waiting, Mesoblast has resubmitted its biologic license application for Ryoncil (remestemcel-L), a potential treatment for children suffering from steroid-refractory acute graft … Read more

Women are often the driving force behind innovation, making up nearly half of the life sciences industry in spite of the lingering wage gap. Their … Read more

Biotech giant BridgeBio’s attempt to monopolize the achondroplasia market was dealt a severe blow on Tuesday, when rival Biomarin announced that the FDA had accepted … Read more

In a time of economic turbulence, one Bay Area biotech, CODA Biotherapeutics, has sadly been forced to close its doors. This is a stark reminder … Read more

The FDA has raised questions about the efficacy and safety of Genentech (Roche)’s Polivy (polatuzumab vedotin-piiq) when used as the first-line treatment for large B-cell … Read more

ASLAN Pharmaceuticals Pte Ltd (Nasdaq: ASLN), a clinical-stage, immunology-focused biopharmaceutical company, is delighted to invite you to join their upcoming virtual research and development day … Read more

Sumitomo Heavy Industries, Ltd. (“SHI”) (TOKYO:6302) (Head Office: Shinagawa-ku, Tokyo, President and CEO: Shinji Shimomura) is excited to announce its investment in Alpha Fusion Inc. … Read more

Tessa Therapeutics Ltd., a clinical-stage cell therapy company, has announced an exciting new partnership with the National Cancer Institute (NCI) of the National Institutes of … Read more

Spinal surgeons at Hospital for Special Surgery in New York City have discovered a revolutionary way to assess the range of motion of youth with … Read more

Mainz Biomed, a molecular genetics diagnostic company specializing in the early detection of cancer, is launching a series of events to spread awareness of the … Read more

Antev Ltd., a pioneering late clinical-stage biotech company, is thrilled to announce that the US Food & Drug Administration (FDA) has granted written guidance on … Read more

Bio-Thera Solutions, Ltd. (SH: 688177) has just announced that the first dose of their cutting-edge antibody-drug conjugate (ADC) has been administered in a Phase 1 … Read more

The U.S. Food and Drug Administration (FDA) recently informed Sage Therapeutics, Inc. (Nasdaq: SAGE) and Biogen Inc. (Nasdaq: BIIB) that it does not intend to … Read more

JW Therapeutics (HKEX: 2126), an independent and pioneering biotechnology company, is making strides in the field of cell immunotherapy with the launch of a clinical … Read more

With the potential to revolutionize the treatment of infectious diseases, cancers and single gene disorders, RNA therapeutics hold immense promise. To make this promise a … Read more

LENZ Therapeutics, a biopharmaceutical company with two late-clinical stage programs, LNZ100 (aceclidine) and LNZ101 (aceclidine and brimonidine) that could be potential best-in-class therapies for presbyopia, … Read more

Spectrum Solutions® is proud to announce their recent acquisitions of Alimetrix, Inc. and Microarrays, Inc. Alimetrix, Inc. is a molecular diagnostic laboratory that specializes in … Read more

Nutcracker Therapeutics, Inc., a biotechnology company committed to developing groundbreaking RNA therapies through its cutting-edge platform, has tapped Angela Peters as its inaugural Chief Human … Read more

MAIA Biotechnology, Inc. (NYSE American: MAIA) is proud to announce that the first two patients have been successfully dosed in Europe in its Phase 2 … Read more

Shorla Oncology, a US-Ireland pharmaceutical company, is proud to announce that its oncology drug, Nelarabine Injection, has been approved by the U.S. Food and Drug … Read more

Xenco Medical, a pioneering surgical technology company, has been named one of the World’s Most Innovative Companies for 2023 by prestigious Fast Company Magazine. The … Read more

At Cowen’s 43rd Annual Healthcare Conference in Boston, Stephen Hoge, President of Moderna, revealed that the company is seeking the FDA’s accelerated approval for their … Read more

Merck made a major breakthrough in the fight against hypercholesterolemia Monday, as the company announced that its investigational drug, MK-0616, had achieved its primary endpoint … Read more

AnPac Bio, a company with operations in the United States and China, has taken a major step in the global cancer detection equipment market with … Read more

BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) received exciting news this afternoon: the U.S. Food and Drug Administration (FDA) extended its review of the company’s Biologics License … Read more

Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, is pleased to announce the appointment of … Read more

Voyager Therapeutics, Inc. (Nasdaq: VYGR), a pioneering biotechnology company dedicated to pushing the boundaries of gene therapy and neurology, has announced that Novartis Pharma AG … Read more

AnPac Bio, a company with operations in the United States and China focused on early cancer screening and detection, announced that on March 2023, it … Read more

Bellerophon Therapeutics, Inc. (Nasdaq: BLPH) announced today that it has entered into an agreement with a life sciences-focused institutional investor to sell 718,474 shares of … Read more

Lantern Pharma, Inc. (NASDAQ: LTRN) has taken a bold step forward in oncology drug development by forming a wholly-owned subsidiary, Starlight Therapeutics Inc., to explore … Read more

Harrow, a prominent U.S. eyecare pharmaceutical company, is pleased to announce the addition of Mark Mannebach, Ph.D., R.Ph. to their team as the new Head … Read more

UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company devoted to creating and commercializing transformative treatments for urothelial and specialty cancers, has granted inducement restricted stock … Read more

Edgewise Therapeutics Inc. (NASDAQ: EWTX) is pleased to announce the appointment of Jonathan C. Fox, M.D., Ph.D., FACC, to its Board of Directors. Dr. Fox … Read more

Adagene Inc. (Nasdaq: ADAG), a company transforming the discovery and development of antibody-based therapies, is proud to welcome Professor Aurélien Marabelle, MD, PhD, to its … Read more

The upcoming week is set to be a quieter one for the FDA, with only two key events scheduled. However, the agency has recently experienced … Read more

PharmAla Biotech Holdings Inc. (CSE: MDMA) is thrilled to announce that it has been named the exclusive supplier of MDMA to Awakn LS Europe Holdings … Read more

The U.K. recently concluded a groundbreaking six-month pilot program that saw 3,000 employees and 61 employers working a four-day workweek instead of the traditional 40 … Read more

Novo Nordisk is investing in the Boston area, with an exciting plan to expand its research and development operations and create over 200 new jobs … Read more

George Church, the renowned geneticist, has launched a new venture that is developing cell therapies to regenerate the thymus, enabling the body to restore and … Read more

Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted therapies for RAS-addicted cancers, has just announced the pricing of its underwritten public offering … Read more

Mirion Technologies, Inc. (NYSE: MIR), a global provider of radiation detection, measurement, analysis, and monitoring solutions to the medical, nuclear, defense, and research end markets, … Read more

Transcenta Holding Limited (HKEX: 06628), a clinically-advanced biopharmaceutical company with capabilities spanning from discovery to manufacturing of antibody-based therapeutics, is proud to announce the successful … Read more

Hansa Biopharma, a leader in enzyme technology for rare immunological conditions, is proud to welcome Matthew Shaulis as Chief Commercial Officer and President of the … Read more

The U.S. Food and Drug Administration’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) has given a ringing endorsement to GlaxoSmithKline’s respiratory syncytial virus vaccine … Read more

MorphoSys AG announced Thursday that it will be taking drastic measures to extend its cash runway, including discontinuing pre-clinical programs and reducing its workforce by … Read more

Expansion Therapeutics, Inc., a biotechnology company dedicated to developing life-changing oral medicines for severe RNA-mediated diseases, is proud to announce the addition of three distinguished … Read more

Dr. John Ballantyne, the co-founder of Aldevron, has made a wise investment of $3M in the sister companies CureLab Oncology, Inc. and CureLab Veterinary. Thanks … Read more

Flamingo Therapeutics and Dynacure have joined forces to form a powerhouse in oncology. The companies have signed a merger agreement to combine their innovative pipelines … Read more

GATC Health Corp, a technology company revolutionizing drug discovery and disease prediction with AI, is proud to welcome Herbert Boyer – the globally renowned biotechnology … Read more

Aurora Spine Corporation, a designer and manufacturer of medical devices that improve spinal surgery outcomes, is proud to announce that its DEXA-C Cervical Interbody System … Read more

Avail Medystems is thrilled to announce that we have been awarded a national group purchasing agreement for telehealth/telemedicine with Premier, Inc., effective January 1, 2023. … Read more

In a major breakthrough, Confo secured a whopping $40 million upfront in a groundbreaking deal with pharmaceutical giant Eli Lilly. This will enable Confo to … Read more

MorphoSys AG (FSE:MOR)(NASDAQ:MOR) today announced that it will be discontinuing its pre-clinical research programs in order to optimize its cost structure. Although the results of … Read more

Genenta Science (NASDAQ: GNTA) is thrilled to announce that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to Temferon™, their … Read more

Biostage, Inc. (OTCQB: BSTG), a clinical-stage biotechnology company developing regenerative-medicine treatments for disorders of the gastro-intestinal system and the airway resulting from cancer, trauma or … Read more

Sarepta Therapeutics, Inc. (NASDAQ:SRPT) has recently taken a major step in its commitment to precision genetic medicine for rare diseases, granting generous equity awards to … Read more

Today, Zymtronix, Inc., a revolutionary biotechnology company, is proud to announce that Dr. Thomas Videbaek, a highly experienced veteran of the biotech industry and former … Read more

Geneoscopy, a leader in the development of groundbreaking diagnostics for gastrointestinal health, is pleased to welcome Don Hardison to its Board of Directors. With more … Read more

Jaguar Health (NASDAQ:JAGX) is pleased to announce that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to crofelemer for the … Read more

FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) is proud to announce the addition of Kevin Harrington, an iconic entrepreneur, to its Advisory Board. … Read more

In a move that stands in stark contrast to the industry trend, AstraZeneca is investing in its future by expanding its R&D operations in Toronto … Read more

Theravance Biopharma has announced that, in order to reduce its headcount by about 17%, it is discontinuing its JAK inhibitor program for lung inflammation. The … Read more

Aptinyx’s hopeful drug, NYX-458, has failed to meet its primary endpoint in a Phase II clinical trial involving patients suffering from cognitive impairment associated with … Read more

Just in time for Rare Disease Day, patients with a rare neuromuscular disorder have been given a life-changing gift: the FDA has approved the first-ever … Read more

On this Rare Disease Day, February 28, the Muscular Dystrophy Association (MDA) celebrates the groundbreaking news from the US Food and Drug Administration (FDA): Omaveloxolone … Read more

Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (OTC: SRBCF) is thrilled to share the exciting results of its research collaboration with the International Centre for … Read more

BioAtla, Inc., a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics for the treatment of solid tumors, today … Read more

Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH) is pleased to announce that the company will release its fourth quarter and full year results on Thursday, March … Read more

Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, is pleased to announce that Nasdaq has granted them a 180-day extension to regain compliance under … Read more

180 Life Sciences Corp. (NASDAQ: ATNF) is thrilled to announce that Professor Jagdeep Nanchahal has been chosen to present at the prestigious Gordon Research Conference … Read more

Microbot Medical Inc. (Nasdaq: MBOT) is proud to announce the expansion of its global reach to South America with the appointment of Francisco C. Carnevale, … Read more

Immuneering Corporation (Nasdaq: IMRX), a clinical-stage oncology company developing innovative medicines to treat a broad range of cancer patients, will be reporting its fourth quarter … Read more

NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, is transforming spine surgery with its minimally disruptive, procedurally integrated solutions. To discuss the company’s … Read more

It’s been two months since California’s Senate Bill 1162, requiring employers to include pay ranges in all job advertisements, took effect – and employers in … Read more

February is set to be a pivotal month for drug approvals, with the FDA poised to deliver three critical decisions. One of these could be … Read more

Fulcrum Therapeutics’ hopes for its potential sickle cell disease (SCD) treatment, FTX-6058, have been put on hold after the US Food and Drug Administration (FDA) … Read more

In an unprecedented year for uniQure, the Massachusetts and Amsterdam-based biotechnology company made history with the U.S. and European approval of the world’s first gene … Read more

Be a part of the puzzle in the ever-evolving therapeutic world with GALLS – a 5,000-piece jigsaw that’s connecting the regulatory edges. As you put … Read more

Reata Pharmaceuticals’ dream of becoming the first to secure FDA approval for an effective treatment of Friedreich’s ataxia (FA) has been put on hold after … Read more

Seagen, the Seattle-based biotech firm, is back in the spotlight after reportedly entering into discussions with pharmaceutical giant Pfizer for a possible acquisition. According to … Read more

After a tumultuous tenure, FDA neuroscience head Dr. Billy Dunn is leaving his post to pursue other opportunities. An internal FDA e-mail revealed the news, … Read more

Alvotech, a global biotech leader in the development and manufacture of life-saving biosimilar medicines, will release its financial results for full year 2022 on Wednesday, … Read more

As the world celebrates Rare Disease Day 2023, RemeGen Co., Ltd. (“RemeGen” or “the Company”) (9995.HK, SHA: 688331) stands in solidarity with the millions of … Read more

Thrive Bioscience Inc. is revolutionizing the field of live cell imaging with their newest Release 4.0 of their CellAssist software. This integrated suite of groundbreaking … Read more

Junshi Biosciences is celebrating a major milestone, having successfully completed two randomized, double-blind, placebo-controlled, multi-center phase III clinical studies (Study nos.: JS002-003 and JS002-006) of … Read more

PharmAla Biotech (CSE:MDMA) is thrilled to announce the unveiling of a revolutionary Patent Cooperation Treaty (PCT) application containing 6 Novel Chemical Entities (NCEs). This application, … Read more

In a move to further streamline its business, Jounce Therapeutics has unveiled an all-stock merger with the clinical-stage biotech Redx Pharma. This restructuring initiative marks … Read more

AbbVie, a global biopharmaceutical company, and Capsida Biotherapeutics have just announced a major collaboration that could potentially change the treatment of eye diseases. With a … Read more

Moderna ended 2022 with a bang, thanks to the success of their Spikevax sales. As they look forward to 2023, the company is investing heavily … Read more

Novartis has decided to discontinue its ex vivo sickle cell disease (SCD) program, which was developed using Intellia Therapeutics’ CRISPR gene editing technology. This news … Read more

Graphite Bio has pulled the plug on its much-anticipated gene therapy for sickle cell disease (SCD), nulabeglogene autogedtemcel (nula-cel). The end of the development of … Read more

Today is World Cochlear Implant Day and MED-EL, a leader in implantable hearing solutions, is celebrating with the millions of people whose lives have been … Read more

Praxis Spinal Cord Institute is thrilled to welcome three cutting-edge technologies to their SCI Incubate program for 2023 — Battelle, inContAlert, and Focal Lines Technologies … Read more

InnoCare Pharma (HKEX: 09969; SSE: 688428) and Keymed Biosciences (HKEX: 02162) made a joint announcement today: the first patient has been dosed with ICP-B05 (CM369), … Read more

Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no. 20045078) is thrilled to invite you to join its conference call on March 2, 2023 at 2:00 pm CET … Read more

PharmaEssentia USA Corporation, a subsidiary of global biopharmaceutical innovator PharmaEssentia Corporation (TPEx:6446), has recently initiated a Phase 2b clinical trial to assess the efficacy of … Read more

AceLink Therapeutics, Inc. has unveiled promising results from their Phase 1 trial of AL01211, a novel therapeutic for genetic diseases. The study demonstrated the medication’s … Read more

AceLink Therapeutics, Inc., a pioneering biopharmaceutical company dedicated to creating life-changing treatments for genetic diseases, has unveiled the promising early results of AL00804, an oral … Read more

Covalon Technologies Ltd. (the “Company” or “Covalon”), an advanced medical technologies company, is pleased to announce its first quarter fiscal 2023 results, ending December 31, … Read more

Glooko Inc. is thrilled to announce a partnering agreement with Sanofi US to better support people living with diabetes and healthcare professionals. The integration of … Read more

Omega Therapeutics, Inc. (Nasdaq: OMGA) has secured an impressive $40 million in a registered direct offering of 6,920,415 Shares of common stock, with a purchase … Read more

Aprea Therapeutics, Inc. (Nasdaq: APRE) is excited to announce the pricing of its public offering of 1,050,000 shares of common stock at a public offering … Read more

At the 19th Annual WORLDSymposium 2023, Astellas presented promising preliminary safety and efficacy data from their Phase I/II FORTIS trial of AT845 in late-onset Pompe … Read more

Apellis Pharmaceuticals, Inc. (Nasdaq:APLS) is excited to announce the pricing of its public offering of 3,174,603 shares of common stock and pre-funded warrants to purchase … Read more

Keymed Biosciences Inc. and Lepu Biopharma Co., Ltd. have today made a landmark agreement with AstraZeneca, granting them exclusive global rights to develop, manufacture and … Read more

On Monday, March 6, 2023, Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, will be releasing their fourth quarter 2022 financial results … Read more

Processa Pharmaceuticals (Heatwurx Acquired Promet), Inc. (Nasdaq: PCSA) (“Processa” or the “Company”) is focused on developing its Next Generation Chemotherapies (NGCs) to improve the safety-efficacy … Read more

Myeloid Therapeutics Inc., a clinical-stage mRNA-immunotherapy company, is taking a major step towards the commercialization of its RNA therapeutics with the announcement of a collaboration … Read more

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) is pleased to announce that management will be participating in Cowen’s 43rd Annual Health Care Conference on Tuesday, March 7, … Read more

Today, IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A) announced that An van Es-Johansson has chosen to step down from her role as a member of … Read more

CareDx, Inc. (Nasdaq: CDNA), The Transplant Company™, is set to report its financial results for the fourth quarter and full year 2022 on Monday, February … Read more

CSL, a global leader in biotechnology, has once again been recognized as one of America’s Best Employers by Forbes and Statista. This is a testament … Read more

Making the transition from academia to industry can be a daunting prospect, but it is often necessary for researchers to bring their therapeutic visions to … Read more

The targeted radiotherapy candidate proved a resounding success, with an impressive 75% of patients achieving initial remission after bone marrow transplant (BMT), compared to a … Read more

Akebia Therapeutics has suffered yet another major setback in the development of vadadustat, a drug designed to treat anemia caused by chronic kidney disease. This … Read more

Pfizer made a major stride forward in the race for an RSV vaccine on Tuesday, as the US Food and Drug Administration (FDA) accepted its … Read more

Hemab Therapeutics has secured a whopping $135 million in its Series B funding round, significantly surpassing its target and paving the way for new treatments … Read more

Ipsen S.A.’s Anemone Acquisition Corp. has extended their tender offer to purchase all of Albireo Pharma, Inc.’s outstanding shares of common stock, at a price … Read more

Relation Therapeutics has taken a major step forward in realising their ambition to establish a revolutionary approach to drug discovery with the opening of their … Read more

C4X Discovery Holdings plc (AIM: C4XD), a pioneering Drug Discovery company, is thrilled to announce the launch of PatientSeek, a groundbreaking precision medicine platform. This … Read more

LinKinVax, a clinical-stage biotechnology company, is thrilled to announce the promising interim results of the ANRS VRI06 Phase I trial evaluating a preventive HIV vaccine. … Read more

NRG Therapeutics, Ltd., a pioneering neuroscience company taking on mitochondrial dysfunction, is delighted to announce that The Michael J. Fox Foundation for Parkinson’s Research (MJFF) … Read more

Vivek Ramaswamy, the founder of Roivant Sciences (Nasdaq: ROIV), has taken a bold step and resigned from his board position to focus on his ambitious … Read more

Avidity Biosciences, Inc. (Nasdaq: RNA) recently granted 27,400 stock options and 13,700 restricted stock units (RSUs) to three new non-executive employees as part of the … Read more

The FDA has just approved Syfovre (pegcetacoplan), developed by Apellis Pharmaceuticals, as the first ever treatment for geographic atrophy (GA). This rare form of blindness … Read more

Eisai is on the brink of a major breakthrough this summer, with the potential full FDA approval of Leqembi (lecanemab), a new drug for Alzheimer’s, … Read more

Thursday brought a flurry of news from Moderna as the company announced the interim results from its Phase III trial of mRNA-1010, a seasonal flu … Read more

Pfizer and Valneva have dealt a major blow to the development of their Lyme disease vaccine candidate, VLA15, after they uncovered potential violations of good … Read more

Clover Biopharmaceuticals, Ltd. is proud to announce an exclusive agreement with Adimmune Corporation that enables Clover to distribute AdimFlu-S (QIS) in mainland China, Bangladesh, Brazil … Read more

Astellas Pharma Inc. has been granted an extended priority review of its investigational agent ‘Fezolinetant’ by the U.S. Food and Drug Administration. Fezolinetant is being … Read more

At the ASCO Genitourinary Cancers Symposium held in San Francisco, Photocure ASA, The Bladder Cancer Company, presented clinical data from the Veterans Affairs (VA) BRAVO … Read more

Medivir AB, a pharmaceutical company dedicated to developing innovative treatments for cancer, has successfully completed the initial dose escalation phase of its 1b/2a study on … Read more

WestVac Biopharma (Guangzhou) Co., Ltd. has made groundbreaking progress on the development of the world’s first trivalent recombinant protein COVID-19 vaccine against the latest prevalent … Read more

Daewoong Pharmaceutical (led by CEO Seng-ho Jeon and Chang-jae Lee) announced an impressive 2022 annual report. On a standalone basis, sales soared by 10.1% to … Read more

GC Biopharma, a South Korean biopharmaceutical leader, is thrilled to announce that its varicella vaccine, BARYCELA, has been prequalified by the World Health Organization (WHO). … Read more

Applied Therapeutics, Inc. (Nasdaq: APLT) is thrilled to announce encouraging sorbitol reduction results from their ongoing global Phase 3 INSPIRE trial. The trial is evaluating … Read more

CareDx, Inc., a pioneering precision medicine company that is transforming the landscape of healthcare solutions for transplant patients and caregivers, is thrilled to showcase its … Read more

Enveda Biosciences has made a major impact on the medical field since its launch in 2019, raising an impressive $124 million to develop small molecules … Read more

Seagen remained silent on the possibility of a buyout from Merck as they reported their fourth-quarter and full-year financial results Wednesday, leaving investors guessing as … Read more

Grifols, a Spanish drugmaker, made waves on Wednesday with the announcement of a sweeping plan to improve its efficiency and cost-effectiveness. Unfortunately, this move will … Read more

Talaris Therapeutics is undergoing a major restructuring, which includes reducing its workforce by one-third and shifting the focus of its pipeline. This move is poised … Read more

Aera Therapeutics has burst onto the scene Thursday, joining forces between an Alynlam vet and a CRISPR big wig to tackle one of the most … Read more

Today, Daiichi Sankyo Co., Ltd. (TSE: 4568) is pleased to announce that it has been granted its request to re-institute post-grant review (PGR) of the … Read more

Abivax SA, a Phase 3 biotechnology company dedicated to developing treatments to modulate the immune system and treat chronic inflammatory diseases, is delighted to welcome … Read more

Pfizer Inc. (NYSE: PFE) and Valneva SE (Nasdaq: VALN; Euronext Paris: VLA) have made the difficult decision to discontinue the participation of a significant portion … Read more

Ascletis Pharma Inc. (HKEX:1672) is proud to announce that their subcutaneous PD-L1 antibody, ASC22 (Envafolimab), has been found to potentially provide a functional cure for … Read more

Tubulis is proud to announce the appointment of Björn Hock, PhD, as its new Chief Development Officer (CDO). With more than two decades of experience … Read more

Enthera Pharmaceuticals, a biotech company pioneering novel biologics for select autoimmune conditions, is pleased to announce the addition of Filippo Canducci MD, PhD to its … Read more

Innovent Biologics, Group (HKEX: 01801), a world-class biopharmaceutical company, has made a major breakthrough in the treatment of plaque psoriasis with the successful dosing of … Read more

Valneva SE, a specialty vaccine company listed on both Nasdaq and Euronext Paris, reported its revenue and cash balance for the full year 2022 and … Read more

Pharming Group N.V. is pleased to announce that the European Medicines Agency’s Committee for Human Medicinal Products has decided to review its Marketing Authorisation Application … Read more

IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a clinical-stage biopharmaceutical company pioneering the development of novel treatments for Parkinson’s disease, will be releasing its year-end … Read more

Eurofins Viracor LLC, a leader in testing for infectious disease, immunology, and allergy, is proud to announce the launch of a revolutionary test that can … Read more

As the Biden-Harris administration’s approved measures move closer to fruition, government agencies are now facing the challenge of putting these policies into action. With 2023 … Read more

Grifols, a Spanish drugmaker, has unveiled a sweeping plan to streamline operations and reduce costs – a decision that will unfortunately result in the loss … Read more

John Reed is making the leap from Sanofi to Johnson & Johnson, where he is set to become the executive vice president of pharmaceuticals, R&D. … Read more

NeoDynamics is delighted to announce that Jie Bao and Xiaojun Xu will be transitioning away from their roles on the Board of Directors to focus … Read more

Cytovation ASA, a clinical stage immune-oncology company, is excited to report that the first patient has been dosed in its Phase 2a study of CyPep-1, … Read more

Formosa Pharmaceuticals (6838.TWO) has entered into an exciting collaboration with Eyenovia, Inc. (NASDAQ: EYEN) to develop innovative ophthalmic products. This groundbreaking agreement brings together Formosa’s … Read more

Gamma Biosciences, a KKR-formed life sciences platform, has taken a major step in the advanced therapy market with its agreement with Swedish life sciences company … Read more

Cutera, Inc. (Nasdaq: CUTR) is set to report its financial results for the fourth quarter and full year of 2022 after the market close on … Read more

Ipsen, Université de Montréal and IRICoR are excited to announce that Ipsen has exercised its option to acquire exclusive rights to a pre-clinical stage program … Read more

Bavarian Nordic A/S (OMX: BAVA) has just announced a major agreement with Emergent BioSolutions Inc. (NYSE: EBS), acquiring two already-marketed travel vaccines, Vivotif® and Vaxchora®, … Read more

Midatech Pharma PLC (AIM:MTPH.L)(NASDAQ:MTP) is pleased to announce the successful closing of its Private Placement of 10,344,822 Units at an issue price of US$0.58 per … Read more

Mainz Biomed is thrilled to announce exciting new partnerships with Marylebone Lab LTD and Instituto de Microecologia, two leading independent laboratories covering England and Spain … Read more

FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) is proud to announce the launch of a new research and development program dedicated to tackling … Read more

Valo Therapeutics Oy (ValoTx), the innovator of adaptive immunotherapies for cancer and infectious diseases, is delighted to announce that it has been awarded a grant … Read more

Encision Inc. (PK:ECIA) is excited to announce that they have signed a Proof of Concept Services Agreement with Vicarious Surgical Inc. The Agreement comes with … Read more

Insulet Corporation (NASDAQ: PODD) – the leader in cutting-edge tubeless insulin pump technology – is pleased to announce that its management team will be presenting … Read more

Lemonex Inc., a biotechnology company at the forefront of mRNA and siRNA therapeutics, recently submitted an Investigational New Drug (IND) application to the Ministry of … Read more

Avanos Medical, Inc. (NYSE: AVNS) is set to release its financial results and business highlights for the fourth quarter and full year of 2022 during … Read more

BioMed X is proud to announce the launch of a revolutionary immunology discovery platform that will revolutionize the way we identify target antigens of human … Read more

Insulet Corporation (NASDAQ: PODD), the global pioneer in tubeless insulin pump technology, has made a major acquisition today with the assets of Automated Glucose Control … Read more

NanoString Technologies, Inc. (NASDAQ:NSTG) is set to report fourth quarter and fiscal year 2022 operating results on Tuesday, February 28, 2023. The leading provider of … Read more

Cullinan Oncology and Harbour BioMed have teamed up to make a revolutionary breakthrough in cancer treatments, introducing CLN-418/HBM7008- a B7H4 x 4-1BB bispecific immune activator … Read more

Frequency Therapeutics Inc. (Nasdaq: FREQ), a regenerative medicine company pioneering treatments to restore function, unveiled promising clinical results from its Phase 2b study of FX-322, … Read more

MAIA Biotechnology, Inc. (NYSE American: MAIA) is launching its second Phase 2 go-to-market trial to evaluate THIO, the world’s first telomere-targeting agent, as a potential … Read more

Jubilant Therapeutics Inc., a clinical stage biopharmaceutical company dedicated to providing small molecule precision therapeutics to address unmet medical needs in oncology and autoimmune diseases, … Read more

Alligator Bioscience AB and Aptevo Therapeutics are delighted to announce that the first patient has been dosed in the companies’ Phase 1 trial of ALG.APV-527, … Read more

BioNxt Solutions Inc. is thrilled to share an update on its commercialization plan for the transdermal Rotigotine patch, a revolutionary treatment for those living with … Read more

IRRAS, a commercial-stage medical technology company, recently announced the publication of the first comparative study detailing the use of their novel IRRAflow system. This study, … Read more

Astex Pharmaceuticals (UK) and The Medicines Discovery Institute, Cardiff University have joined forces in a multi-million pound, multi-year collaboration to discover novel small molecule therapeutics … Read more

Aristea Therapeutics has made the difficult decision to terminate its Phase II lead program RIST4721 due to safety concerns, resulting in the dissolution of its … Read more

LegoChem Biosciences Inc. (KOSDAQ:141080) has just announced an exciting new license agreement with Elthera AG, a Swiss biotechnology company. This agreement will enable LegoChemBio to … Read more

IASO Biotherapeutics (IASO Bio), a clinical-stage biopharmaceutical company dedicated to discovering, developing, and manufacturing innovative cell therapies and antibody products, is delighted to announce that … Read more

AstraZeneca made a major shift in priorities Thursday, announcing a sweeping cut to its pipeline of drugs in an effort to counterbalance its declining COVID-19 … Read more

Bayer’s supervisory board has responded to investor and shareholder demands by unanimously appointing Bill Anderson, an outsider, as their new CEO. Anderson will step into … Read more

Magenta Therapeutics has announced a dramatic restructuring that will drastically reduce its workforce, with up to 56 positions being eliminated – a massive 84 percent … Read more

AbbVie’s much-anticipated Humira cliff has arrived, and the biopharma giant is feeling the impact on its 2023 projections. After releasing Q4 and annual 2022 results … Read more

Nykode Therapeutics ASA, a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel immunotherapies, is teaming up with the GOG Foundation, Inc. to … Read more

Today, Evotec SE – a Frankfurt Stock Exchange-listed MDAX/TecDAX and NASDAQ-traded company – and the European Investment Bank (EIB) are pleased to announce a € … Read more

ALK has announced that Claus Steensen Sølje will join their ranks as Executive Vice President and Chief Financial Officer (CFO) from June 1, 2023. He … Read more

At the BriaCell Therapeutics Corp. Annual General and Special Meeting of Shareholders for the year ended July 31, 2022, a resounding success was seen with … Read more

Nona Biosciences, a cutting-edge technology innovator and wholly-owned subsidiary of HBM Holdings Limited, has entered into an exciting collaboration with Mythic Therapeutics, a biotechnology company … Read more

InMed Pharmaceuticals Inc. has taken the initiative to file a Form 12b-25 with the SEC in connection with its Quarterly Report on Form 10-Q for … Read more

Verily, an Alphabet company focused on precision health, is pleased to announce the appointment of Utpal Koppikar as their new Chief Financial Officer. With an … Read more

Vapotherm Inc. (NYSE: VAPO), a global medical technology company committed to the development and commercialization of its proprietary Vapotherm high velocity therapy® products, has recently … Read more

John Quisel, J.D., Ph.D., Chief Executive Officer and President of Disc Medicine, Inc. (NASDAQ:IRON), will take part in a virtual fireside chat at the SVB … Read more

Halberd Corporation (OTC PINK:HALB) has achieved remarkable success with its patent-pending extracorporeal laser eradication process. Through an experimental process conducted by Dr. Chester Cooper and … Read more

Abbott Laboratories (NYSE: ABT) and Cardiovascular Systems, Inc. (CSI) have reached a deal that will see Abbott acquire CSI, a medical device company with a … Read more

Sterling Medical Devices, a leader in the medical device industry, is proud to announce their merger with RBC Medical Innovations. This strategic move brings additional … Read more

Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) has released its financial and operational results for the third quarter of its fiscal year 2023, ending December 31, … Read more

23andMe, the leading human genetics and biopharmaceutical company, announced its financial results for the third quarter of its fiscal year 2023, ending December 31, 2022. … Read more

ADMA Biologics, Inc. (NASDAQ: ADMA) is excited to announce that the company has received U.S. Food and Drug Administration (“FDA”) approval for its eighth ADMA … Read more

Samsung’s United States headquarters of digital radiography and ultrasound, Boston Imaging, introduces the HERA W10 Elite1; the most advanced model of the HERA platform for … Read more

CHOP has been awarded an incredible $2.3 million from the Bill & Melinda Gates Foundation to power crucial mitochondria medicine research and unlock the mystery … Read more

Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking medical device company that created Swoop®, the world’s first FDA-cleared portable MRI system™, is proud to announce the appointment … Read more

Visage Imaging, Inc., a subsidiary of Pro Medicus Ltd., is thrilled to be the proud recipient of the #1 Universal Viewer (Imaging) ranking in the … Read more

After nearly six years of successful service at Align Technology, Inc., Yuval Shaked, executive vice president and managing director of iTero scanner and services, is … Read more

Jaguar Health Inc. (NASDAQ:JAGX) had good news to share on February 7, 2023, as the Company was notified by The Nasdaq Stock Market LLC (“Nasdaq”) … Read more

Lazurite has announced its schedule of upcoming events, where it will be exhibiting, presenting, or attending in support of its revolutionary ArthroFree® wireless camera system … Read more

Heska Corporation (NASDAQ: HSKA), a leading global provider of advanced veterinary diagnostic and specialty solutions, will reveal its fourth quarter and full year 2022 financial … Read more

Curio Bioscience has just taken a giant leap forward in the world of gene expression mapping with the launch of Curio Seeker – the world’s … Read more

West Pharmaceutical Services, Inc. (NYSE: WST) is proud to announce the expansion of its game-changing collaboration with Corning Incorporated (NYSE: GLW), granting exclusive distribution rights … Read more

EnPlusOne Biosciences, Inc., a biotechnology company utilizing the power of enzymes to synthesize RNA oligonucleotides, is proud to welcome Jonathan K. Watts, Ph.D., to its … Read more

Palisade Bio, Inc. (Nasdaq: PALI), a clinical stage biopharmaceutical company committed to developing therapies for GI complications, is pleased to announce the promotion of Robert … Read more

PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company, has taken a major step forward in the fight against infectious diseases, including SARS-CoV-2 and multiple … Read more

Synos Health®, the leading biopharmaceutical solutions organization, is proud to announce their strategic partnership with Equicare, leveraging proXimity™, a cloud-based software platform that expedites the … Read more

T-knife Therapeutics, Inc., a clinical-stage biopharmaceutical company, is proud to announce the appointment of Behzad Kharabi Masouleh, M.D. as Chief Medical Officer. Dr. Masouleh will … Read more

Nimbus Therapeutics, a clinical-stage company that designs and develops breakthrough medicines, announced the closing of Takeda’s (TSE: 4502/NYSE:TAK) acquisition of its wholly-owned subsidiary, Nimbus Lakshmi, … Read more

Summit Healthcare Acquisition Corp. (Nasdaq: SMIH), and YishengBio Co., Ltd (to be renamed YS Biopharma Co., Ltd.) have received SEC approval for their proposed business … Read more

Hoth Therapeutics, Inc., a patient-focused biopharmaceutical company, has released revolutionary proof-of-concept data demonstrating the potential therapeutic cognitive effects of its experimental drug, HT-ALZ, in an … Read more

Ostial Corporation, a revolutionary medical technology company, just announced a major funding milestone: a $7M growth round led by Delos Capital, with AMED Ventures and … Read more

The Mark Foundation for Cancer Research has unveiled the latest round of recipients of its Drug Discovery Award – an ambitious program designed to fast-track … Read more

aTyr Pharma, Inc. (Nasdaq: LIFE) has begun an exciting new public offering of its common stock, giving investors the opportunity to be part of a … Read more

Garuda Therapeutics is revolutionizing the medical field with their groundbreaking cell therapy technology. The company recently secured a $62 million Series B round to further … Read more

Roche and Janssen Biotech Inc. are collaborating to bring the next level of precision medicine to patients. By creating companion diagnostics for targeted therapies, Roche … Read more

Celyad Oncology, a biotechnology company focused on the development of innovative treatments for CAR T-cell therapies, has announced the publication of the data from the … Read more

Lunit and Agfa HealthCare have achieved a major milestone in breast imaging technologies with the successful implementation of the Breast AI Analysis Package at Dubai … Read more

Brendan Swift is joining ATF Medical, a national leader in complex rehab technology and accessibility solutions for workers’ compensation, as Vice President of Payer Partnerships … Read more

Vertex has provided an update on the late-stage clinical development of its next-in-class triple combination treatment for cystic fibrosis, vanzacaftor/tezacaftor/deutivacaftor, amidst increasing demands for generic … Read more

The WHO has bestowed an esteemed honor upon GC Biopharma, the leading biopharmaceutical provider in South Korea. On February 3rd, 2023, the WHO granted prequalification … Read more

The tech industry and the life sciences have been forging an ever-closer alliance in recent years. By 2030, the pharma industry is projected to invest … Read more

In the wake of the opioid crisis, finding long-term, non-addictive solutions to manage chronic pain in the U.S. has become an urgent priority for biopharma, … Read more

On February 9th, the FDA’s Oncologic Drugs Advisory Committee (ODAC) will be discussing GSK’s Jemperli (dostarlimab) and its potential to receive accelerated approval for treatment … Read more

Sensorion, a clinical-stage biotechnology company at the forefront of developing novel therapies for the treatment of hearing loss disorders, is pleased to announce that the … Read more

Pliant Therapeutics launched a public offering of its common stock on Monday, with a total of $175 million up for grabs. The proceeds from the … Read more

Babson Diagnostics is revolutionizing the healthcare industry with its cutting-edge technology, BetterWay™ Blood Testing. This innovative diagnostic blood testing service puts the customer first, ensuring … Read more

CoImmune, Inc., a clinical stage immuno-oncology company working to revolutionize cancer treatment with cutting-edge cellular immunotherapies, has unveiled exciting preclinical results in Blood, the leading … Read more

Cardiff Oncology, Inc. (Nasdaq: CRDF), a forward-thinking biotechnology company developing innovative therapies for a range of cancers, is proud to announce the appointment of Fairooz … Read more

Recent studies have exposed a worrying connection between CRISPR gene editing and ancestry: individuals with greater genomic diversity, such as those of African descent, have … Read more

The US Food and Drug Administration (FDA) has given the green light to GSK’s daprodustat, now branded as Jesduvroq, for treating anemia related to chronic … Read more

Patient Square Capital is rewriting the rules of the game when it comes to investing in bear markets and sky-high inflation. On Thursday, they announced … Read more

Karuna Therapeutics has made an exciting move, acquiring exclusive rights to Goldfinch Bio’s investigational transient receptor potential canonical 4 and 5 (TRPC4/5) channel candidates in … Read more

Roche has decided to discontinue development of its experimental AKT inhibitor ipatasertib, which had been under investigation in a Phase III trial for castration-resistant prostate … Read more

Structure Therapeutics Inc., a clinical-stage global biopharmaceutical company, is pleased to announce the pricing of its upsized initial public offering of 10,740,000 American depositary shares … Read more

Roivant Sciences, Inc. (Nasdaq: ROIV) announced the successful pricing of an upsized public offering of 26,666,666 of its common shares at a price of $7.50 … Read more

Dr. Anton (Tony) Hoos is set to become the new Head of R&D and Medical Affairs, Chief Medical Officer, and member of the Sobi Executive … Read more

Vera Therapeutics, Inc. (NasdaqGM: VERA) is delighted to announce the pricing of its underwritten public offering, offering 14,285,715 shares of its Class A common stock … Read more

TAU Systems, a leading provider of ultrafast, compact plasma accelerators, is proud to announce its recent agreements with The University of Texas at Austin (UT … Read more

BerGenBio ASA (OSE: BGBIO), a clinical-stage biopharmaceutical company dedicated to developing innovative AXL kinase inhibitors to address severe unmet medical needs, is proud to announce … Read more

NeoDynamics AB (Nasdaq First North Growth Market Stockholm: NEOD.ST) is thrilled to announce their new partnership with global distribution and logistics giant Uniphar Group to … Read more

Sequana Medical NV (Euronext Brussels: SEQUA), a leader in the field of fluid overload treatment for liver disease, heart failure and cancer patients, will reveal … Read more

Sensorion, an innovative clinical-stage biotechnology company, is excited to announce their participation in the Association for Research in Otolaryngology (ARO) 46th Annual MidWinter Meeting in … Read more

Fourth quarter Sales of SEK 855 (514) million soared by an impressive 66% in SEK, driven by organic growth of 11%, 37% acquired growth, and … Read more

OCTOBER – DECEMBER IN BRIEF During the quarter, the company achieved net sales of KSEK 142, a significant increase from the KSEK 99 reported in … Read more

Anaveon, a clinical stage immuno-oncology company, is excited to announce the first patient has been dosed in the OMNIA-1 study – a Phase I/II study … Read more

On Tuesday, uniQure announced an exciting collaboration with Apic Bio to develop and commercialize APB-102, a potential therapeutic treatment for a rare, genetic form of … Read more

With a colossal $150 million Series B financing round, Colossal Biosciences has taken a giant leap towards the de-extinction of the beloved Dodo – extinct … Read more

Sirnaomics Ltd., a cutting-edge biopharmaceutical company in the discovery and development of RNAi therapeutics, is thrilled to announce that it is making strides in the … Read more

Occlutech Holding AG, a leader in providing cutting-edge minimally invasive structural heart disease devices, is proud to announce the appointment of Dr. Morwan Choli as … Read more

Bronwyn Brophy, an Irish national, possesses an impressive resume of leadership positions in some of the world’s most prominent Life Science and Medtech organizations, such … Read more

Ellipses Pharma, a pioneering drug development company committed to transforming cancer treatment, is delighted to announce that the U.S. Food and Drug Administration (FDA) has … Read more

AviadoBio, a groundbreaking gene therapy company at the forefront of developing and delivering life-changing treatments for those suffering from neurodegenerative disorders, is proud to announce … Read more

Adicet Bio, Inc. (Nasdaq: ACET) made a major move on January 31, 2023, granting inducement awards to further its mission of discovering and developing allogeneic … Read more

Sequana Medical NV (Euronext Brussels: SEQUA) proudly announces the granting of a new US patent for its revolutionary DSR (Direct Sodium Removal) program. This groundbreaking … Read more

Amgen (NASDAQ:AMGN) recently held its 2022 fourth quarter and full year financial results webcast, and the full transcript and audio replay are now available for … Read more

Biopharmaceutical innovator Alpha Biopharma proudly announces that the National Medical Products Administration’s Center for Drug Evaluation (CDE) has accepted its New Drug Application (NDA) for … Read more

Aprecia Pharmaceuticals is proud to announce Owen Murray as its new Chief Executive Officer. With Murray at the helm, Aprecia is set to revolutionize the … Read more

Dr. Pavankumar Tandra, a board-certified hematologist and medical oncologist, has joined Florida Cancer Specialists & Research Institute, LLC (FCS)! He is now providing exceptional care … Read more

Moderna’s RSV vaccine candidate has been granted a Breakthrough Therapy Designation by the FDA, a major step forward in the fight against the debilitating respiratory … Read more

Novartis’ hope for a therapeutic breakthrough in the treatment of sickle cell disease, Adakveo (crizanlizumab), is currently under review by the European Medicines Agency’s Committee … Read more

Eli Lilly’s revolutionary new drug, Jaypirca (pirtobrutinib), has just been granted accelerated approval by the FDA for treating adults with relapsed or refractory mantle cell … Read more

Boston is a haven for biotech, boasting an impressive concentration of life sciences companies and the financial resources to back them up. It’s clear that … Read more

Sensorion and EVEON have joined forces to design and develop a revolutionary injection system for the delivery of Sensorion’s gene therapy products to the inner … Read more

On Monday, Amgen confirmed to BioSpace that it is making significant organizational changes, including the layoff of around 300 team members, in order to better … Read more

C-mo Medical Solutions is revolutionizing cough assessment and disease management with the power of digital health! With the recent funding from Novalis Biotech, this pioneering … Read more

MaaT Pharma (EURONEXT: MAAT), a French clinical-stage biotech, is revolutionizing the field of cancer treatment with its pioneering Microbiome Ecosystem TherapiesTM (MET). The Company has … Read more

Sensient Technologies Corporation (NYSE: SXT) is ready to share its fourth quarter and year-end results for 2022 on Friday, February 10, 2023. Join us as … Read more

Kaiser Permanente is proud to announce the appointment of Angela Dowling as their new regional president in Washington. Starting February 13, 2023, she will be … Read more

More than 40 of the world’s most esteemed ophthalmologists, vision researchers, and public health/policy experts are gathering in Mexico for the 2nd Mexico-U.S. Symposium on … Read more

Community Financial Institutions (CFIs) play a vital role in promoting economic and social justice in underserved communities. By providing products and services tailored to the … Read more

Hospital for Special Surgery (HSS) today announced a historic transition for 2023, as Bryan T. Kelly, MD, MBA will become the first surgeon to assume … Read more

Just in time for American Heart Month, XyloCor Therapeutics has released positive topline results from their Phase I/II trial of their groundbreaking gene therapy for … Read more

Merck’s revolutionary cancer treatment, Keytruda (pembrolizumab), has been officially approved by the FDA for the treatment of stage IB, II or IIIA non-small cell lung … Read more

Celularity made a startling announcement on Thursday, revealing that it was undertaking a strategic review and warning its employees to brace for possible job losses. … Read more

Sen. Elizabeth Warren (D-MA) is expressing her concerns about the high-priced acquisitions of Horizon Pharmaceuticals and Opiant Pharmaceuticals by Amgen and Indivior, respectively, in a … Read more

Jaguar Health, Inc. is taking a bold step forward in its mission to make a difference in the rare and orphan disease space. Through its … Read more

Bone Biologics Corporation, a leader in developing orthobiologic products for spine fusion markets, is thrilled to announce their collaboration with Avania, a renowned global, full-service … Read more

BioCentriq, Inc., a New Jersey-based CDMO for cell and gene therapies, has just concluded a study to evaluate the viability, transfection efficiency, and post-transfection growth … Read more

Nogra Pharma, a biotechnology company dedicated to creating groundbreaking therapies for immune-inflammatory-mediated diseases, has just announced a major licensing agreement with Torii Pharmaceutical Co., Ltd. … Read more

Panbela Therapeutics Inc., a clinical stage company developing groundbreaking therapeutics for the treatment of patients with urgent unmet medical needs, has announced the pricing of … Read more

The COVID-19 pandemic has sparked an increased demand for biopharma candidates, with the neuroscience field experiencing a particularly noticeable surge. As this sector continues to … Read more

A startling revelation was made on Tuesday – a previously unknown syndrome with a high mortality rate is far more common than previously thought. The … Read more

Ocuphire Pharma is forging ahead with an FDA end-of-Phase II meeting, despite not achieving the primary endpoint with its oral diabetic retinopathy (DR) drug, APX3330. … Read more

Magenta Therapeutics has placed an immediate pause on the Phase I/II dose-escalation trial of its AML therapy following the unfortunate death of a patient. The … Read more

AC Immune’s anti-amyloid-beta vaccine candidate ACI-24.060 has, according to interim data from the Phase Ib/II ABATE trial, been found to be safe and effective in … Read more

Enlivex Therapeutics Ltd. has made a significant breakthrough in their pioneering macrophage reprogramming immunotherapy clinical trial, as an independent Data and Safety Monitoring Board has … Read more

Today, a review providing evidence-based treatments for early stage Dupuytren’s disease has been published in The Journal of Hand Surgery (European Volume) by 180 Life … Read more

Inhibikase Therapeutics, Inc. has made a breakthrough in the battle against Parkinson’s and related disorders. The company recently published a study in Science Translational Medicine … Read more

Phio Pharmaceuticals Corp., a clinical stage biotechnology company, is taking a bold step forward with its INTASYL™ RNAi platform technology. On January 26, 2023, the … Read more

Jasper Therapeutics, Inc., a biotechnology company that is revolutionizing the field of medicine with its novel antibody therapies, has announced the pricing of an underwritten … Read more

Acasti Pharma Inc., a late-stage specialty pharma company developing treatments for rare and orphan diseases, has been granted a 180-day extension by the NASDAQ Listing … Read more

Clearmind Medicine Inc., a pioneering biotech company devoted to uncovering and developing novel psychedelic-derived therapeutics, proudly announced today that Professor Joseph Tam, D.M.D., Ph.D., presented … Read more

On Wednesday, Small Pharma made a major breakthrough in the development of treatment for major depressive disorder (MDD) when they reported positive results from their … Read more

On Wednesday, three venture capitalists unveiled an exciting new endeavor: Dimension I, a $350 million fund to revolutionize the biotech industry. With this bold move, … Read more

Wednesday was an eventful day for Merck’s blockbuster drug Keytruda (pembrolizumab), as it suffered a rare setback in prostate cancer while simultaneously celebrating a major … Read more

Sanford Burnham Prebys is proud to announce a major recruitment drive, with up to 20 new faculty positions set to be filled in the fields … Read more

Cerevance, a groundbreaking clinical-stage drug discovery and development company focused on central nervous system (CNS) diseases, is proud to announce that Craig Thompson, the company’s … Read more

Dyadic International, Inc., a pioneering biotechnology company, has made a major breakthrough in the fight against COVID-19. The company has initiated dosing in its Phase … Read more

HeartBeam Inc. (NASDAQ: BEAT), a groundbreaking cardiac technology company, is delighted to welcome Robert Eno to their executive team in the newly created position of … Read more

Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) is thrilled to welcome Michael Nketiah to its leadership team as Senior Vice President of Quality, Clinical and Regulatory. … Read more

Avadel Pharmaceuticals plc, a biopharmaceutical company focused on improving treatments to improve lives, recently unveiled real-world data showing the risk of accidental dosing errors with … Read more

The discovery of the genetic basis of VEXAS syndrome in 2020 was a major breakthrough in medical research. But how many people in the United … Read more

Axcella Therapeutics is making strides in the fight against Long COVID fatigue with its AXA1125 therapeutic. On Monday, the U.K.’s Medicines and Healthcare products Regulatory … Read more

On March 22nd, Biogen and Ionis’ experimental therapy for superoxide dismutase 1 (SOD1) ALS, Tofersen, will have its fate in the hands of the FDA’s … Read more

Monday marked a major milestone for Pliant Therapeutics, as the company launched its public offering of $175 million worth of common stock. These funds will … Read more

Tracy Curley, CEO of iSpecimen Inc. (Nasdaq: ISPC), is excited to be part of the Sequire Biotechnology Conference on Thursday, February 2, 2023. As an … Read more

Hemogenyx Pharmaceuticals plc is delighted to announce the successful completion of its third Process Qualification run of the end-to-end manufacturing process for its HEMO-CAR-T cells. … Read more

Today, IntelGenx Corp, a leader in pharmaceutical films, has entered into an exclusive supply agreement with ARWAN Pharmaceuticals Industries Lebanon s.a.l. for their revolutionary product, … Read more

Alvotech, a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, is pleased to announce the completion of a … Read more

MannKind Corporation, a leader in the development and commercialization of inhaled therapeutic products to treat endocrine and orphan lung diseases, today announced the launch of … Read more

Asensus Surgical Inc. has made a thrilling leap forward in medical technology with the CE Mark approval of expanded machine vision capabilities on the previously-cleared … Read more

Today, AstraZeneca, through a subsidiary, begins a tender offer to purchase all outstanding shares of CinCor Pharma, Inc. (CinCor) for a combined $36 per share … Read more

Estar Medical® has had a string of successes this month in its efforts to invalidate Regenlab’s original patent for platelet rich plasma (PRP) at the … Read more

Today, Smart Immune SAS, a clinical-stage biotechnology company, made an exciting announcement: the first adult leukemia patient has been successfully dosed with SMART101, a revolutionary … Read more

Helius Medical Technologies, Inc., a neurotech company with a mission to promote neurological wellness, is pleased to announce preliminary, unaudited results for the quarter and … Read more

On Monday, February 20th, 2023, TC BioPharm (Holdings) PLC, a clinical stage biotechnology company developing platform allogeneic gamma-delta T cell therapies for cancer, will be … Read more

Catalent, Inc. (NYSE: CTLT) – the global leader in developing, launching and supplying better treatments for patients – will be releasing its financial results for … Read more

Join VolitionRX Limited (NYSE AMERICAN: VNRX) for an exciting webinar hosted by Edison Group! During the event, Volition’s multi-national epigenetics company will be discussing their … Read more

Jazz Pharmaceuticals’ $375 million investment into Zymeworks appears to be a smart move, as the two companies announced “impressive” results on Thursday from a Phase … Read more

CancerVAX, Inc., a pre-clinical biotechnology company on a mission to develop powerful immunotherapy cancer treatments, is proud to announce that CEO Ryan Davies recently shared … Read more

Dr. Reddy’s Laboratories Ltd., a world-leading pharmaceutical company, has achieved a major milestone with the successful completion of all clinical trials for its proposed rituximab … Read more

At SK bioscience, we are dedicated to promoting global health and wellbeing from prevention to cure. Through our cutting-edge vaccine development technologies, we are standing … Read more

SK bioscience, a global leader in innovative vaccine and biotech solutions that prioritize human health, has welcomed Richard Kensinger, PhD, to the team as Vice … Read more

Deciphera Pharmaceuticals, a biopharmaceutical company dedicated to discovering and developing innovative medicines to improve the lives of cancer patients, has announced the pricing of a … Read more

At the American Association for Cancer Research (AACR) special conference on acute myeloid leukemia and myelodysplastic syndrome, taking place January 23-25, 2023 in Austin, TX, … Read more

ANGLE plc, a revolutionary liquid biopsy company, is pleased to welcome Dr. Joseph (Joe) Eid to its board of Non-Executive Directors. Dr. Eid’s appointment will … Read more

Annogen is working to create multiple CNS-cell specific promoters that can be used in VectorY programs. This innovative approach will help to further advance the … Read more

Prenetics Global Limited, a leader in the fields of genomic and diagnostic testing, is proud to announce the appointment of Dr. Bayju Thakar as CEO … Read more

Scenic Biotech, a leader in the groundbreaking world of genetic modifier drugs, has announced the appointment of Kristof Van Emelen, PhD, as Vice President of … Read more

XNK Therapeutics AB has appointed Dr. Peter Hovstadius as its new Chief Medical Officer, effective immediately. He will join the company’s management team, while Dr. … Read more

Last week, NRx Pharmaceuticals, Inc., a clinical-stage central nervous system (CNS) biopharmaceutical company, had a productive meeting with the Food and Drug Administration (FDA), who … Read more

AVAIL SCIENTIFIC is thrilled to announce that it is taking an exciting step forward by entering into a letter of intent (LOI) to acquire Relai … Read more

Teva Pharmaceuticals Industries Ltd is proud to have its targets to reduce greenhouse gas (GHG) emissions approved by the Science Based Targets initiative (SBTi), demonstrating … Read more

Repare Therapeutics Inc., a cutting-edge clinical-stage precision oncology company, announced that it has received a research service payment of approximately $1.5 million (¥200 million) from … Read more

Normunity, Inc., a biotechnology company creating innovative precision anti-cancer immunotherapies, is thrilled to announce the appointment of Olga Granaturova, MBA, as Chief Operating Officer and … Read more

SurModics, Inc. announced that they have received a letter from the U.S. Food and Drug Administration (FDA) regarding their premarket approval (PMA) application for the … Read more

bluebird bio, Inc. announced the pricing of its public offering of 20,000,000 shares of common stock at a public offering price of $6.00 per share, … Read more

Kaneka Corporation is taking the initiative to expand its GMP manufacturing capacity for mRNA with a capital investment of 2 billion JPY. By the end … Read more

Addex Therapeutics Ltd, a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, today provided a comprehensive corporate update from its headquarters in Geneva, … Read more

KDDI Corporation, based in Tokyo, is proud to announce that its ambitious greenhouse gas (GHG) emissions reduction targets have been validated and approved by the … Read more

Junshi Biosciences announced Wednesday that their Phase III Neotorch trial of the anti-PD-1 monoclonal antibody, toripalimab, had achieved its primary endpoint in non-small cell lung … Read more

Novavax, Inc. (Nasdaq: NVAX), a biotechnology company developing next-generation vaccines for serious infectious diseases, is proud to announce that its partner SK bioscience has received … Read more

BeiGene is making history by expanding access to life-changing drugs in China! For the first time ever, drugs are being added to the nation’s Reimbursement … Read more

BriaCell Therapeutics Corporation is delighted to announce that its lead clinical candidate, Bria-IMT™, in combination with a checkpoint inhibitor, has been met with agreement and … Read more

The Lupus Research Alliance (LRA) is delighted to announce the appointment of Stacie J. Bell, PhD as Executive Vice President to head up Lupus Therapeutics, … Read more

Cryoablation technology is at the forefront of innovation, and we are proud to be a global leader in this field. Our success is evidenced by … Read more

SOFIE Biosciences, a renowned US-based manufacturer of radiopharmaceuticals, is proud to announce its support of Yantai LNC Biotechnology’s recently FDA-approved clinical study – with the … Read more

Ceruvia Lifesciences made history today, dosing the first participant in their Phase 1 clinical trial of NYPRG-101 (2-bromo-d-lysergic acid diethylamide). The pioneering trial marks an … Read more

Researchers have been able to pinpoint the lowest effective dose of a medication or therapy, thanks to a successful study. This breakthrough provides an invaluable … Read more

Perimeter Medical Imaging AI, Inc. (TSX-V: PINK, OTC: PYNKF, FSE: 4PC) – a commercial-stage medical technology company – is proud to announce its new Board … Read more

Exploring the role of gamma-delta T cells in oncological settings is an exciting area of research with potentially groundbreaking implications. By devoting our attention to … Read more

Aclarion, Inc., a healthcare technology company utilizing biomarkers and proprietary augmented intelligence algorithms to help physicians determine the source of chronic low back pain, is … Read more

A recent study published in the Journal of Clinical Medicine has validated the efficacy of Biobeat’s wrist monitor for advanced noninvasive hemodynamic monitoring in heart … Read more

Agilis RoboticsTM (Agilis) is revolutionizing endoscopic surgery with its groundbreaking robotic instruments. Co-founder Dr. Jason Y.K. Chan recently completed a successful live animal test on … Read more

OncoK9’s potential for detecting cancer recurrence and residual disease after surgery or treatment is impressive, as evidenced by the results of PetDx’s analysis. With its … Read more

Ascletis Pharma Inc. (HKEX: 1672), a China-based biopharmaceutical company, announced today that its wholly owned subsidiary Ascletis Pharmaceuticals Co., Ltd. has entered into a supply … Read more

Scientists from the University of Texas Southwestern Medical Center have made a remarkable breakthrough: using base editing technology, they have managed to repair damaged heart … Read more

We are delighted to report that our clinical trial has produced positive results on both primary and secondary endpoints, allowing us to identify a dose … Read more

World’s First Approved Biosimilar to Actemra® Bio-Thera Solutions, Ltd., a commercial-stage biopharmaceutical company based in Guangzhou, China, has just made a major breakthrough in medical … Read more

CARsgen Therapeutics Holdings Limited (2171.HK) and Huadong Medicine (Hangzhou) Co., Ltd., a subsidiary of Huadong Medicine Co., Ltd. (SZ: 000963), have joined forces in an … Read more

Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA) is delighted to announce a placement of KZA shares to institutional and sophisticated investors in Australia, at a … Read more

Predictive Oncology Inc. (NASDAQ: POAI) is thrilled to announce the appointment of Robert F. Murphy, Ph.D. to its Scientific Advisory Board. With his expertise and … Read more

Cytovance Biologics, a premier biopharmaceutical CDMO of mammalian and microbial biologics, is proud to announce the appointment of Ping Zhang as its new Chief Executive … Read more

Silence Therapeutics plc, Nasdaq: SLN (“Silence” or “the Company”), a pioneering biotechnology company dedicated to improving lives by developing precision-engineered medicines to silence diseases, provided … Read more

Introducing CliniPrime Fresh Leukopak, the revolutionary technology that will revolutionize clinical trials and advance the commercialization of advanced therapies. With this launch, we are revolutionizing … Read more

BIOLASE, Inc., the leading global provider of dental lasers, was recently honored with the prestigious Top Workplaces 2022 award from the Orange County Register. The … Read more

Extendicare Inc. (TSX: EXE) declared a cash dividend of C$0.04 per Common Share for the month of January 2023, to be paid out on February … Read more

BioArctic AB’s partner, Eisai, has recently submitted a marketing authorization application for lecanemab, an investigational anti-amyloid beta (Aβ) protofibril[1] antibody for the treatment of mild … Read more

EDP Biotech Corporation is thrilled to welcome Sam Libby as their new Head of Mergers & Acquisitions and Corporate Development. With Libby’s expertise on board, … Read more

VolitionRx Limited (NYSE AMERICAN: VNRX) is proud to announce the launch of its revolutionary Nu.Q® Vet Cancer Test, now available in the United States through … Read more

ALiA BioTech’s rapid diagnostic platform is capable of providing up to 30 accurate results from a single drop of body fluid – whether it be … Read more

Eisai Co., Ltd. and Biogen Inc. have made a groundbreaking announcement today: they have jointly submitted a marketing authorization application for lecanemab, a revolutionary anti-amyloid … Read more

Clover Biopharmaceuticals, Ltd. (Clover; HKEX: 02197) has made a commitment to use innovative vaccines to save lives and improve public health across the world. Today, … Read more

Enrolling 72 healthy volunteers, we are excited to launch a multiple-dose escalation Phase I clinical trial in the first quarter of 2023. Be a part … Read more

Eli Lilly had an incredible year with the launch of their diabetes drug Mounjaro (tirzepatide). Now, the company is gearing up for an even bigger … Read more

As JP Morgan week kicked off in 2023, Alto Neuroscience was named number seven on BioSpace’s NextGen Bio 2023 list and brought with it positive … Read more

At the 41st J.P. Morgan Healthcare Conference in San Francisco, AbbVie’s CEO Rick Gonzalez talked about the company’s plans to adjust to the impending loss … Read more

Midatech Pharma PLC is delighted to announce that their Phase I study of MTX-110 in recurrent glioblastoma (NCT 05324501) will continue with a planned dose … Read more

IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a Gothenburg-based company developing pioneering treatments for Parkinson’s disease, has nominated a drug candidate from its P003 research … Read more

Pixium Vision has achieved a major milestone — the publication of two peer-reviewed studies showcasing the potential of the Next Generation PRIMA implant to restore … Read more

Biophytis SA (NasdaqCM: BPTS)(Euronext Growth Paris: ALBPS), a clinical-stage biotechnology company focused on the development of therapeutics to slow the degenerative processes of aging and … Read more

Oramed Pharmaceuticals Inc. (Nasdaq/TASE: ORMP), a clinical-stage pharmaceutical company dedicated to the development of oral drug delivery systems, has released the top-line results of its … Read more

iNtRON Biotechnology is delighted to announce that their Tech Transfer process for SAL200, a revolutionary endolysin-based biologic, is entering its final stage! This out-licensing and … Read more